Educational Video Series

Thomas Gross, MD, PhD

Thomas Gross

Thomas G. Gross, MD, PhD, is the Deputy Director of Science for the Center for Global Health at the National Cancer Institute in Rockville, MD.

Dr. Gross graduated with a BS degree with honors in Biochemistry from the University of Nebraska.  He earned a combined MD-PhD degree, from the University of Nebraska Medical Center (UNMC). After completing a Pediatric residency at the UNMC, he received fellowship training in Pediatric Hematology/Oncology at the University of Minnesota.   He then went back to become a faculty member in the Departments of Pediatrics and Pathology at UNMC from 1993-1998.  He subsequently, became the Director of the Blood and Marrow Transplant  (BMT) program at Cincinnati Children’s Hospital Medical Center from 1998-2002.  From 2002 until the summer of 2013, he was the Division Chief and Gordon Teter Chair for Cancer Research at Nationwide Children’s Hospital in Columbus Ohio.

Dr. Gross’s honors include membership in the Alpha Omega Alpha Medical Honor Society; several endowed visiting professorships, an NIH Merit Award and America’s Top Doctors and The Best Doctors in America.

Dr. Gross has authored over 100 peer-reviewed manuscripts and textbook chapters. His areas of research interests include lymphomas and cancers associated with immune deficiency.  He has chaired several national/international clinical trials funded by the NIH.  He has served as a leader in Children’s Oncology Group including Chair of the Non-Hodgkin Lymphoma Disease Committee, the Scientific Chairs Committee, and the Data Safety Monitoring Board (DSMB), as well as serving on the Scientific Council and the Executive Committee.  Dr. Gross has chaired or served on numerous DSMBs, including the current Chair of the Histiocyte Society DSMB.  He has also served on numerous advisory committees for pharmaceutical companies and the FDA, for the development of new agents in the treatment of cancer. In his new position in the Center for Global Health at the US NCI, he is responsible for facilitating international research and clinical trials for cancer and other rare disease, such as the histiocytic diseases.

Dr. Gross’s involvement in the histiocytosis began with his research and care for patients with HLH caused by Epstein-Barr virus.  He values the camaraderie and intellectual exchange of the Histiocyte Society and understands the necessity and is committed to international collaboration for the advancement in the treatment of rare diseases like histiocytosis.



View Dr. Gross' video: Importance of Clincial Trials
Return to Educational Video Series page

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   

¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: Nosotros podremos responderle tan pronto nos sea possible. Gracias!